Literature DB >> 2196110

Association of point mutation in c-Ki-ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes.

T Kobayashi1, H Tsuda, M Noguchi, S Hirohashi, Y Shimosato, T Goya, Y Hayata.   

Abstract

The correlation between clinicopathologic findings and point mutation in codon 12 of c-Ki-ras gene was examined in primary lung adenocarcinomas using polymerase chain reaction and oligonucleotide hybridization techniques. The mutation was detected in ten of 67 cases (15%). Microscopically, mutation-positive cases revealed a tendency to be well differentiated (P less than 0.01). Especially, the incidence of the mutation-positive cases was significantly higher in goblet cell type (three of four) than in other types (five of 56) (P less than 0.001). None of 21 cases of pure Clara cell type showed the mutation (P less than 0.05). The mutation was detected frequently in tumors with no lymph node metastasis (P less than 0.05), with larger tumor size (P = 0.01), and T2 cases (P less than 0.01). Cigarette smoking was not always a contributing factor for mutation. This study revealed that the point mutation of c-Ki-ras codon 12 in lung adenocarcinoma has been associated with the cytologic subtype.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2196110     DOI: 10.1002/1097-0142(19900715)66:2<289::aid-cncr2820660216>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

Review 2.  Do all lung adenocarcinomas follow a stepwise progression?

Authors:  Yasushi Yatabe; Alain C Borczuk; Charles A Powell
Journal:  Lung Cancer       Date:  2011-06-25       Impact factor: 5.705

Review 3.  Novel insights into the molecular origins and treatment of lung cancer.

Authors:  James D Webb; M Celeste Simon
Journal:  Cell Cycle       Date:  2010-10-11       Impact factor: 4.534

4.  Growth regulation via insulin-like growth factor binding protein-4 and -2 in association with mutant K-ras in lung epithelia.

Authors:  Hanako Sato; Takuya Yazawa; Takehisa Suzuki; Hiroaki Shimoyamada; Koji Okudela; Masaichi Ikeda; Kenji Hamada; Hisafumi Yamada-Okabe; Masayuki Yao; Yoshinobu Kubota; Takashi Takahashi; Hiroshi Kamma; Hitoshi Kitamura
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

5.  K-ras gene mutations: an unfavorable prognostic marker in stage I lung adenocarcinoma.

Authors:  E M Silini; F Bosi; N S Pellegata; G Volpato; A Romano; S Nazari; C Tinelli; G N Ranzani; E Solcia; R Fiocca
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

6.  High K-ras mutation rates in goblet-cell-type adenocarcinomas of the lungs.

Authors:  E Tsuchiya; R Furuta; N Wada; K Nakagawa; Y Ishikawa; B Kawabuchi; Y Nakamura; H Sugano
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

7.  Detection of codon 12 K-ras mutations in non-neoplastic mucosa from bronchial carina in patients with lung adenocarcinomas.

Authors:  T Urban; S Ricci; C Danel; M Antoine; M Kambouchner; V Godard; R Lacave; J F Bernaudin
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

8.  The Role of KRAS Mutational Analysis to Determine the Site of Origin of Metastatic Carcinoma to the Lung: A Case Report.

Authors:  Ahmad Alkhasawneh; Ahmed N Alkhasawneh; Hui-Jia Dong; Chen Liu; Carmen Allegra; Robert W Allan
Journal:  Case Rep Pathol       Date:  2012-10-17

Review 9.  Tobacco and cancer: epidemiology and the laboratory.

Authors:  P Vineis; N Caporaso
Journal:  Environ Health Perspect       Date:  1995-02       Impact factor: 9.031

10.  Detection of ras gene mutations in human lung cancer: comparison of two screening assays based on the polymerase chain reaction.

Authors:  K Husgafvel-Pursiainen; M Ridanpää; P Hackman; S Anttila; A Karjalainen; A Onfelt; A L Børresen; H Vainio
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.